Composition
- Active ingredients
- SODIUM NITROPRUSSIDE 50MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SODIUM NITROPRUSSIDE 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA018450-001 · Discontinued
- SODIUM NITROPRUSSIDE 25MG/ML · InjectableANDA071961-001 · Discontinued
- SODIUM NITROPRUSSIDE 50MG/VIAL · InjectableANDA071555-001 · Discontinued
- SODIUM NITROPRUSSIDE 50MG/VIAL · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA070566.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Nitropress
- Active substance
- sodium nitroprusside
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Hospira
- Status
- Discontinued
- FDA approval
- 9 Jun 1986
- Application
- ANDA070566-001